GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sugentech Inc (XKRX:253840) » Definitions » Equity-to-Asset

Sugentech (XKRX:253840) Equity-to-Asset : 0.88 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sugentech Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sugentech's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₩108,592 Mil. Sugentech's Total Assets for the quarter that ended in Mar. 2024 was ₩124,122 Mil. Therefore, Sugentech's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.88.

The historical rank and industry rank for Sugentech's Equity-to-Asset or its related term are showing as below:

XKRX:253840' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.27   Med: 0.78   Max: 0.89
Current: 0.88

During the past 7 years, the highest Equity to Asset Ratio of Sugentech was 0.89. The lowest was 0.27. And the median was 0.78.

XKRX:253840's Equity-to-Asset is ranked better than
93.56% of 233 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58 vs XKRX:253840: 0.88

Sugentech Equity-to-Asset Historical Data

The historical data trend for Sugentech's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sugentech Equity-to-Asset Chart

Sugentech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.54 0.87 0.65 0.81 0.84

Sugentech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.82 0.84 0.84 0.88

Competitive Comparison of Sugentech's Equity-to-Asset

For the Diagnostics & Research subindustry, Sugentech's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sugentech's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sugentech's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Sugentech's Equity-to-Asset falls into.



Sugentech Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Sugentech's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=112394.84/133187.019
=0.84

Sugentech's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=108591.572/124122.196
=0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sugentech  (XKRX:253840) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Sugentech Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Sugentech's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sugentech (XKRX:253840) Business Description

Traded in Other Exchanges
N/A
Address
87, Techno 2-ro, Yuseong-gu, Daejeon, KOR
Sugentech Inc is an in-vitro diagnostic company. It is developing and selling products that can diagnose many types of diseases based on various platforms such as self-diagnostics home testing products (Self-testing) and Point-of-care testing(POCT) products.

Sugentech (XKRX:253840) Headlines

No Headlines